Ridgewood Investments LLC Purchases 4,336 Shares of Smith & Nephew plc (NYSE:SNN)

Ridgewood Investments LLC lifted its position in Smith & Nephew plc (NYSE:SNN) by 6.1% during the 4th quarter, Holdings Channel reports. The firm owned 75,979 shares of the medical equipment provider’s stock after buying an additional 4,336 shares during the quarter. Smith & Nephew makes up 0.9% of Ridgewood Investments LLC’s investment portfolio, making the stock its 18th biggest holding. Ridgewood Investments LLC’s holdings in Smith & Nephew were worth $1,868,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. International Assets Investment Management LLC bought a new stake in shares of Smith & Nephew in the 3rd quarter worth about $792,000. Sanctuary Advisors LLC bought a new stake in Smith & Nephew during the 2nd quarter worth about $627,000. Bank of Montreal Can grew its holdings in Smith & Nephew by 355.8% during the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after acquiring an additional 964,762 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Smith & Nephew by 29.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 27,199 shares of the medical equipment provider’s stock worth $847,000 after acquiring an additional 6,164 shares during the last quarter. Finally, Stifel Financial Corp bought a new stake in Smith & Nephew during the 3rd quarter worth about $1,258,000. Institutional investors own 25.64% of the company’s stock.

Analyst Ratings Changes

SNN has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Berenberg Bank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th.

Smith & Nephew Trading Down 1.2 %

Shares of NYSE:SNN traded down $0.29 during mid-day trading on Friday, reaching $24.03. The stock had a trading volume of 272,837 shares, compared to its average volume of 1,144,325. The firm has a market cap of $10.51 billion, a PE ratio of 12.26, a price-to-earnings-growth ratio of 1.41 and a beta of 0.84. The firm has a 50 day simple moving average of $25.02 and a two-hundred day simple moving average of $27.76. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63. Smith & Nephew plc has a twelve month low of $23.65 and a twelve month high of $31.72.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.